JP2023535771A5 - - Google Patents
Info
- Publication number
- JP2023535771A5 JP2023535771A5 JP2023505421A JP2023505421A JP2023535771A5 JP 2023535771 A5 JP2023535771 A5 JP 2023535771A5 JP 2023505421 A JP2023505421 A JP 2023505421A JP 2023505421 A JP2023505421 A JP 2023505421A JP 2023535771 A5 JP2023535771 A5 JP 2023535771A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- hydrogen
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056861P | 2020-07-27 | 2020-07-27 | |
| US63/056,861 | 2020-07-27 | ||
| PCT/US2021/042711 WO2022026285A1 (en) | 2020-07-27 | 2021-07-22 | Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535771A JP2023535771A (ja) | 2023-08-21 |
| JP2023535771A5 true JP2023535771A5 (enExample) | 2024-06-17 |
| JP7695339B2 JP7695339B2 (ja) | 2025-06-18 |
Family
ID=80038102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505421A Active JP7695339B2 (ja) | 2020-07-27 | 2021-07-22 | インフルエンザを治療又は予防するための多環式キャップ依存性エンドヌクレアーゼ阻害薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240018145A1 (enExample) |
| EP (1) | EP4188379B1 (enExample) |
| JP (1) | JP7695339B2 (enExample) |
| KR (1) | KR20230044252A (enExample) |
| CN (1) | CN116490190A (enExample) |
| AU (1) | AU2021315475A1 (enExample) |
| BR (1) | BR112023001325A2 (enExample) |
| CA (1) | CA3187516A1 (enExample) |
| MX (1) | MX2023001194A (enExample) |
| WO (1) | WO2022026285A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250154090A1 (en) * | 2022-03-01 | 2025-05-15 | Firmenich Sa | Process for preparing gamma,delta-unsaturated aldehydes derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5475109A (en) * | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
| MX2008005137A (es) * | 2005-10-27 | 2008-09-29 | Shionogi & Co | Derivado de carbamoilpiridona policiclica que tiene actividad inhibidora en vih integrasa. |
| DK2620436T3 (en) * | 2010-09-24 | 2018-07-30 | Shionogi & Co | Substituted polycyclic carbamoylpyridone derivative prodrug |
| TWI695003B (zh) * | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| EP4257137A3 (en) * | 2018-05-31 | 2023-11-01 | Shionogi & Co., Ltd | Polycyclic carbamoylpyridone derivatives for the treatment of hiv |
| MA52802A (fr) * | 2018-05-31 | 2021-04-14 | Shionogi & Co | Dérivé de pyridone polycyclique |
| WO2020055858A1 (en) * | 2018-09-10 | 2020-03-19 | Cocrystal Pharma, Inc. | Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication |
-
2021
- 2021-07-22 US US18/015,465 patent/US20240018145A1/en active Pending
- 2021-07-22 CA CA3187516A patent/CA3187516A1/en active Pending
- 2021-07-22 KR KR1020237006229A patent/KR20230044252A/ko active Pending
- 2021-07-22 CN CN202180065598.0A patent/CN116490190A/zh active Pending
- 2021-07-22 JP JP2023505421A patent/JP7695339B2/ja active Active
- 2021-07-22 WO PCT/US2021/042711 patent/WO2022026285A1/en not_active Ceased
- 2021-07-22 MX MX2023001194A patent/MX2023001194A/es unknown
- 2021-07-22 EP EP21848925.0A patent/EP4188379B1/en active Active
- 2021-07-22 BR BR112023001325A patent/BR112023001325A2/pt unknown
- 2021-07-22 AU AU2021315475A patent/AU2021315475A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6364028B2 (ja) | 選択的エストロゲン受容体ディグレーダーとしてのベンゾチオフェン誘導体およびその組成物 | |
| JP2021513534A5 (enExample) | ||
| JP2023551174A5 (enExample) | ||
| JP2020527175A5 (enExample) | ||
| JP2024516033A5 (enExample) | ||
| RU2005137403A (ru) | Новые замещенные 3-сера-индолы | |
| JP2010514832A5 (enExample) | ||
| RU2018115569A (ru) | Оксаспиропроизводное, способ его получения и его применения в лекарственных средствах | |
| CN115605479A (zh) | 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用 | |
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| JP2011509309A5 (enExample) | ||
| RU2009136592A (ru) | Терапевтические агенты | |
| JP2010510237A5 (enExample) | ||
| RU2007102288A (ru) | Новые тиазольные ингибиторы фруктозо-1,6-бисфосфатазы | |
| JP2021512109A5 (enExample) | ||
| RU2007124329A (ru) | ПРОИЗВОДНЫЕ 5-ГИДРОКСИБЕНЗОТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ β2 АДРЕНОРЕЦЕПТОРОВ | |
| JP2014528464A5 (enExample) | ||
| JP2010535790A5 (enExample) | ||
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JP2020511536A5 (enExample) | ||
| JP2011509302A5 (enExample) | ||
| JP2012518634A5 (enExample) | ||
| JP2010505898A (ja) | エストロゲン受容体リガンドとして有用な２−フェニルインデン誘導体 | |
| JP2019529460A5 (enExample) | ||
| JP2009501775A (ja) | 癌治療におけるチアゾール誘導体およびアナログの使用 |